EP Patent

EP1004594A1 — Phytosterol and/or phytostanol derivatives

Assigned to DSM IP Assets BV · Expires 2000-05-31 · 26y expired

What this patent protects

Phytosterol and/or phytostanol esters with polyunsaturated fatty acids having from 18 to 22 carbon atoms and at least three carbon-carbon double bonds are effective in reducing both serum cholesterol and trglycerides.

USPTO Abstract

Phytosterol and/or phytostanol esters with polyunsaturated fatty acids having from 18 to 22 carbon atoms and at least three carbon-carbon double bonds are effective in reducing both serum cholesterol and trglycerides.

Drugs covered by this patent

Patent Metadata

Patent number
EP1004594A1
Jurisdiction
EP
Classification
—
Expires
2000-05-31
Drug substance claim
No
Drug product claim
No
Assignee
DSM IP Assets BV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.